A Single Arm Phase II Trial Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Early Relapsing Metastatic Triple Negative Breast Cancer (BELLA)

Project: Research

Project Details

StatusActive
Effective start/end date24/06/2123/06/26

Keywords

  • phase 2 study
  • breast cancer
  • treatment safety
  • treatment efficacy